Intervention
Laboratory Biomarker Analysis
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 424 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownAn Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung CancerNCT05558904 · 2023-01-19
RECRUITINGRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296 · 2021-02-21
RECRUITINGProstate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyNCT04472338 · 2020-05-21
RECRUITINGS1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityNCT03418961 · 2017-11-01
RECRUITINGBeating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerNCT03199651 · 2017-07-17
RECRUITINGMulticenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyNCT02945579 · 2017-01-20
RECRUITINGCytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusNCT02479698 · 2015-07-23
RECRUITINGWhole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast CancerNCT02610413 · 2014-03-25
RECRUITINGWhole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast CancerNCT02610426 · 2014-03-25
RECRUITINGWhole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast CancerNCT02610439 · 2014-03-25
RECRUITINGEffects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentNCT01790152 · 2014-03-05
RECRUITINGCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerNCT01050504 · 2009-08-01
RECRUITINGIncidence of HIV Infection in Screening Indian Men Who Have Sex With MenNCT04142385 · 2027-04-30
WITHDRAWNIncidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive MenNCT04142398 · 2027-04-30
WITHDRAWNEffects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerNCT05244434 · 2022-07-03
WITHDRAWNSerial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyNCT04692103 · 2021-07-10
ACTIVE_NOT_RECRUITINGPomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus InfectionNCT03601806 · 2021-04-26
COMPLETEDStudy of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLCNCT04754815 · 2021-04-01
WITHDRAWNGermline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA TrialNCT04624256 · 2020-11-10
ACTIVE_NOT_RECRUITINGDonor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesNCT02962661 · 2020-07-18
SUSPENDEDFluid Biopsy for the Diagnosis of Lung CancerNCT04162678 · 2020-01-13
TERMINATEDHPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPVNCT03284866 · 2019-07-31
COMPLETEDExercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerNCT03091842 · 2019-07-29
WITHDRAWNHigh-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate CancerNCT03514927 · 2019-07-01
WITHDRAWNM6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate CancerNCT03517969 · 2019-05-29
ACTIVE_NOT_RECRUITINGGallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryNCT03515577 · 2019-04-12
COMPLETEDBrigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid CancersNCT03868423 · 2019-03-20
WITHDRAWNPhysical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer SurvivorsNCT03120390 · 2019-03-08
WITHDRAWNGinseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsNCT03407716 · 2019-03-01
COMPLETEDTesting the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisNCT03317392 · 2019-02-04
ACTIVE_NOT_RECRUITINGHistamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the BoneNCT03529565 · 2019-01-31
TERMINATEDPropranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryNCT03152786 · 2019-01-15
TERMINATEDGenetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS StudyNCT04254133 · 2018-11-30
ENROLLING_BY_INVITATIONEnzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate CancerNCT03344211 · 2018-11-21
ACTIVE_NOT_RECRUITINGEvaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and VincristineNCT03596918 · 2018-10-10
COMPLETEDPembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural MesotheliomaNCT03126630 · 2018-10-04
ACTIVE_NOT_RECRUITINGALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung CancerNCT03402880 · 2018-10-01
WITHDRAWNPI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryNCT03218826 · 2018-09-24
COMPLETEDVGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal LesionsNCT03603808 · 2018-09-21
COMPLETEDEndocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerNCT03238703 · 2018-09-01
WITHDRAWNTestosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerNCT03516812 · 2018-08-29
COMPLETEDRadium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate CancerNCT03361735 · 2018-08-29
ACTIVE_NOT_RECRUITINGDocetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair DeficiencyNCT03442556 · 2018-08-24
TERMINATEDPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)NCT03526250 · 2018-08-13
COMPLETEDAnetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung CancerNCT03455556 · 2018-08-10
TERMINATEDFulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast CancerNCT03377101 · 2018-08-07
WITHDRAWNRibociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast CancerNCT03477396 · 2018-06-14
COMPLETEDPembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate CancerNCT03406858 · 2018-06-07
COMPLETEDErdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)NCT03210714 · 2018-06-05
ACTIVE_NOT_RECRUITINGDurvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT02966587 · 2018-05-15
WITHDRAWNGlembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryNCT03326258 · 2018-04-20
WITHDRAWNMRI Characterization of Mammographically Detected DCISNCT03495011 · 2018-04-20
ACTIVE_NOT_RECRUITINGTreatment of Refractory Nausea and Vomiting in Patients With Breast CancerNCT03367572 · 2018-04-19
COMPLETEDExercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsNCT03523195 · 2018-04-18
COMPLETEDEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)NCT03213652 · 2018-04-17
ACTIVE_NOT_RECRUITINGBronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerNCT02937402 · 2018-04-05
TERMINATEDDirect Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerNCT03432741 · 2018-03-27
TERMINATEDNaloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerNCT03087708 · 2018-03-23
TERMINATEDTherapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate CancerNCT03456843 · 2018-03-20
ACTIVE_NOT_RECRUITINGIbrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasNCT03220022 · 2018-03-16
ACTIVE_NOT_RECRUITINGCommon conditions
Recurrent Breast Carcinoma59HER2/Neu Negative51Stage IV Breast Cancer AJCC v6 and v744Triple-Negative Breast Carcinoma42Estrogen Receptor Negative36Stage IV Breast Cancer35Progesterone Receptor Negative33Stage IIIB Breast Cancer33Stage IIIC Breast Cancer33Stage IIIA Breast Cancer32Estrogen Receptor Positive29Recurrent Prostate Carcinoma29Prostate Adenocarcinoma28Invasive Breast Carcinoma27Recurrent Non-Small Cell Lung Carcinoma27Stage IIIC Breast Cancer AJCC v727Stage IV Non-Small Cell Lung Cancer27Stage IIA Breast Cancer26Stage IIB Breast Cancer26Stage IIIA Breast Cancer AJCC v723Stage IIIB Breast Cancer AJCC v723Metastatic Prostate Carcinoma22Stage IIIB Non-Small Cell Lung Cancer21Stage IIIA Non-Small Cell Lung Cancer20Hormone-Resistant Prostate Cancer19
Leading sponsors
National Cancer Institute (NCI)132M.D. Anderson Cancer Center45University of Washington27University of Southern California21Mayo Clinic17Roswell Park Cancer Institute17City of Hope Medical Center16Jonsson Comprehensive Cancer Center13Fred Hutchinson Cancer Center12SWOG Cancer Research Network12Northwestern University9Wake Forest University Health Sciences9AIDS Malignancy Consortium7Ohio State University Comprehensive Cancer Center6OHSU Knight Cancer Institute6
Trial status mix
COMPLETED210
ACTIVE_NOT_RECRUITING84
TERMINATED79
WITHDRAWN27
RECRUITING12
SUSPENDED5
UNKNOWN5
ENROLLING_BY_INVITATION1
NO_LONGER_AVAILABLE1
Phase mix
PHASE2205
PHASE1121
NA58
PHASE339
EARLY_PHASE16
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.